CD46 and atypical hemolytic-uremic syndrome: In addition to C3GP, AP abnormality is also implicated in thrombotic microangiopathy (TMA), including atypical hemolytic uremic syndrome (aHUS), as suggested by mutations in C3, CFI, CD46, and CFH found in patients with aHUS (Feitz et al., 2018).